Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy
ConditionReproductive Issues
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-42
SponsorChinese University of Hong Kong
About this trial
Hypotheses:
We hypothesize that serum progesterone levels on the day of embryo transfer in HRT-FET cycles are positively associated with clinical pregnancy rates.
Aims:
To evaluate the relationship between serum progesterone levels on embryo transfer day and clinical pregnancy outcomes in frozen-thawed embryo transfer cycles using hormone replacement therapy (HRT).
Primary outcome:
To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing frozen embryo transfer with caterized Progesterone level on the day of embryo transfer
Secondary outcomes:
Biochemical pregnancy rate. Implantation rate. Early pregnancy loss rate. Ectopic pregnancy rate.
Eligibility criteria
Qualifiers
Patients undergoing FET cycles
Infertility patients aged >18 years old and < 42 years old
BMI < 30 kg/m2
Transfer of at least one good-quality embryo.
Disqualifiers
Severe endocrine disorders (e.g., thyroid dysfunction, premature ovarian failure).
Severe uterine factors without treatment (severe endometriosis, extensive or subendometrial fibroid, uterine adherent, endometrial polyps)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov